234 related articles for article (PubMed ID: 17611488)
1. Technology insight: therapeutic RNA interference--how far from the neurology clinic?
Gonzalez-Alegre P; Paulson HL
Nat Clin Pract Neurol; 2007 Jul; 3(7):394-404. PubMed ID: 17611488
[TBL] [Abstract][Full Text] [Related]
2. [Therapeutic RNA interference for neurodegenerative diseases].
González-Alegre P
Rev Neurol; 2008 Dec 16-31; 47(12):641-7. PubMed ID: 19085881
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic RNA interference for neurodegenerative diseases: From promise to progress.
Gonzalez-Alegre P
Pharmacol Ther; 2007 Apr; 114(1):34-55. PubMed ID: 17316816
[TBL] [Abstract][Full Text] [Related]
4. Viral-based modelling and correction of neurodegenerative diseases by RNA interference.
Raoul C; Barker SD; Aebischer P
Gene Ther; 2006 Mar; 13(6):487-95. PubMed ID: 16319945
[TBL] [Abstract][Full Text] [Related]
5. Silencing neurodegenerative disease: bringing RNA interference to the clinic.
Rodriguez-Lebron E; Gonzalez-Alegre P
Expert Rev Neurother; 2006 Feb; 6(2):223-33. PubMed ID: 16466302
[TBL] [Abstract][Full Text] [Related]
6. RNAi therapy for neurodegenerative diseases.
Boudreau RL; Davidson BL
Curr Top Dev Biol; 2006; 75():73-92. PubMed ID: 16984810
[TBL] [Abstract][Full Text] [Related]
7. RNA interference based gene therapy for neurological disease.
Jagannath A; Wood M
Brief Funct Genomic Proteomic; 2007 Mar; 6(1):40-9. PubMed ID: 17478451
[TBL] [Abstract][Full Text] [Related]
8. RNA interference and potential therapeutic applications of short interfering RNAs.
Karagiannis TC; El-Osta A
Cancer Gene Ther; 2005 Oct; 12(10):787-95. PubMed ID: 15891770
[TBL] [Abstract][Full Text] [Related]
9. [RNA interference--towards individualized genetic medicine].
Corydon TJ; Mikkelsen JG
Ugeskr Laeger; 2006 Dec; 168(50):4401-4. PubMed ID: 17217865
[TBL] [Abstract][Full Text] [Related]
10. MicroRNAs in common diseases and potential therapeutic applications.
Tsai LM; Yu D
Clin Exp Pharmacol Physiol; 2010 Jan; 37(1):102-7. PubMed ID: 19671070
[TBL] [Abstract][Full Text] [Related]
11. Promises and challenges in developing RNAi as a research tool and therapy for neurodegenerative diseases.
Xia XG; Zhou H; Xu Z
Neurodegener Dis; 2005; 2(3-4):220-31. PubMed ID: 16909029
[TBL] [Abstract][Full Text] [Related]
12. Gene therapy: panacea or placebo? II. Main applications of gene therapy.
Górecki DC; MacDermot KD
Arch Immunol Ther Exp (Warsz); 1997; 45(5-6):375-81. PubMed ID: 9437493
[TBL] [Abstract][Full Text] [Related]
13. Gene transfer therapy for neurodegenerative disorders.
Feigin A; Eidelberg D
Mov Disord; 2007 Jul; 22(9):1223-8; quiz 1369. PubMed ID: 17393533
[TBL] [Abstract][Full Text] [Related]
14. Allele-specific RNA interference for neurological disease.
Rodriguez-Lebron E; Paulson HL
Gene Ther; 2006 Mar; 13(6):576-81. PubMed ID: 16355113
[TBL] [Abstract][Full Text] [Related]
15. RNA interference as potential therapy for neurodegenerative disease: applications to inclusion-body myositis?
Paulson H
Neurology; 2006 Jan; 66(2 Suppl 1):S114-7. PubMed ID: 16432138
[TBL] [Abstract][Full Text] [Related]
16. RNA interference in neuroscience.
Genc S; Koroglu TF; Genc K
Brain Res Mol Brain Res; 2004 Dec; 132(2):260-70. PubMed ID: 15582163
[TBL] [Abstract][Full Text] [Related]
17. [Application of RNAi in gene-deficient models].
Tan YL; Yin QW
Yi Chuan Xue Bao; 2005 Apr; 32(4):434-41. PubMed ID: 16011036
[TBL] [Abstract][Full Text] [Related]
18. Silencing polyglutamine degeneration with RNAi.
Bonini NM; La Spada AR
Neuron; 2005 Dec; 48(5):715-8. PubMed ID: 16337909
[TBL] [Abstract][Full Text] [Related]
19. RNA interference for the treatment of cancer.
Putral LN; Gu W; McMillan NA
Drug News Perspect; 2006; 19(6):317-24. PubMed ID: 16971967
[TBL] [Abstract][Full Text] [Related]
20. Ribonucleic acid interference for neurological disorders: candidate diseases, potential targets, and current approaches.
Federici T; Boulis NM
Neurosurgery; 2007 Jan; 60(1):3-15; discussion 15-6. PubMed ID: 17228249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
